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Abstract
Background: Despite great efforts to improve diagnosis and treatment, tuberculosis (TB) remains a major health problem
worldwide, especially in developing countries. Lack of concrete immune markers is still the obstacle to properly evaluate
active TB. Therefore, identification of more validated biomarkers and phenotypic signatures is imperative. In particular, T
cell-related biomarkers are more significant.
Methodology: To understand the nature of CD4
+ T cell-derived signatures involved in infection and disease development,
we examined and analyzed whole genome expression profiles of purified CD4
+ T cells from healthy individuals (HD), two
distinct populations with latent infection (with low or high IFN-c levels, LTBL/LTBH) and untreated TB patients. Following, we
validated the expression profiles of genes in the peripheral CD4
+ T cells from each group and examined secretion levels of
distinct cytokines in serum and pleural effusion.
Principal Findings: Our bio-informatic analyses indicate that the two latent populations and clinical TB patients possess
distinct CD4
+ T cell gene expression profiles. Furthermore, The mRNA and protein expression levels of B cell activating factor
(BAFF), which belongs to the TNF family, and a proliferation-inducing ligand (APRIL) were markedly up-regulated at the
disease stage. In particular, the dramatic enhancement of BAFF and APRIL in the pleural effusion of patients with
tuberculosis pleurisy suggests that these proteins may present disease status. In addition, we found that the BAFF/APRIL
system was closely related to the Th1 immune response. Our study delineates previously unreported roles of BAFF and
APRIL in the development of tuberculosis, and these findings have implications for the diagnosis of the disease. Our study
also identifies a number of transcriptional signatures in CD4
+ T cells that have the potential to be utilized as diagnostic and
prognostic tools to combat the tuberculosis epidemic.
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Introduction
Despite efforts to improve diagnosis and treatment, tuberculosis
(TB) remains a profound burden on global health, especially in
developing countries [1]. Mycobacterium Tuberculosis (M.tb)
infection can be controlled in most infected individuals. However,
in a minority of cases (5,10%), the failure to contain the infection
induces active tuberculosis [2]. Similar to the active disease, latent
tuberculosis also includes a diverse range of patients [1–3]. This
diversity makes the study of tuberculosis difficult, and more
efficient tools are needed to further characterize the disease.
A well-used approach to the study of complex diseases is
genome-wide transcriptional analysis. Previous studies have
successfully obtained useful information regarding specific dis-
ease-associated signatures and the pathogenesis of tuberculosis
using transcriptome analysis[4–6]. These studies have analyzed
the gene expression profiles of cells involved in the immune
response [5,7,8]. Scanning of purified peripheral blood mononu-
clear cells (PBMCs) rather than whole blood is also a common
method [9] because it allows the identification of a set of signatures
for differentiating tuberculosis patients from healthy individuals
(including latent tuberculosis patients) [4,6] and discriminating the
subtle differences [5].
CD4
+ T cell-mediated immune responses play pivotal roles in
controlling the growth of M.tb and maintaining the homeostasis
of the host [10]. IFN-c is a cytokine that strongly promotes the T
helper 1 (Th1) cell response, and it has also been demonstrated
to act as a protective factor against tuberculosis in human and
animal studies [10]. The IFN-c release assay is widely used in
helping to diagnose M.tb infection. However, the debate of its
clinic use continues as IFN-c release assay fails to distinguish
between LTBI and active TB. In our study, participants with
latent infection were segregated into two groups according to
M.tb-specific IFN-c spot-forming cells (SFCs), as determined by a
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[11,12]. We discovered that two latent groups (low IFN-c
expression group with lower SFCs and high IFN-c expression
group with higher SFCs) possessed distinct gene expression
profiles in their purified peripheral CD4
+ T cells. Importantly, a
subset of latent individuals (with high IFN-c expression) had
transcriptional signatures similar to those of active tuberculosis
patients [5], In addition, we detected an increase in the
expression of BAFF and APRIL during the disease stage, but
not in latency population. The strong expression levels of BAFF
and APRIL in the pleural effusion of patients with tuberculosis
pleurisy (TP) further indicated their effects on disease status and
in extrapulmonary TB. Moreover, soluble APRIL correlated with
IFN-c expression level in the pleural effusion of patients with TP,
which suggests that the correlation between APRIL and IFN-c
may be useful for predicting tuberculosis.
Materials and Methods
Subjects and Samples
Healthy individuals with no history of tuberculosis disease,
smear positive untreated pulmonary tuberculosis patients (TB,
n=39), and patients with tuberculosis pleurisy (TP, n=21) were
recruited from the Tuberculosis hospital, China. The tuberculin
skin test (TST) and a previously established M.tb-specific IFN-c
ELISPOT assay [11] were employed to differentiate latent
tuberculosis participants (LTB, n=68) from healthy donors (HD,
n=50). Furthermore, the participants in the LTB group were
segregated into two groups according to SFC counts: LTBL
(n=35, 30,80 SFCs) and LTBH (n=33, 110,400 SFCs).
Pulmonary cancer patients (CA, n=14) were recruited as a
disease control. Clinical diagnosis of pulmonary TB and TP was
based on signs and symptoms, roentgenographic findings (Chest
X-ray and/or HRCT) consistent with TB and sputum bacterium
examination. All participants were HIV-negative, had no autoim-
mune diseases and were not subjected to immunosuppressant
treatments. The subjects’ characteristics are summarized in
Table 1.
PBMCs were isolated from heparinized whole blood, and
CD4+ T cells were directly purified from PBMCs using
magnetic beads (BD Biosciences). Total RNA was extracted
from purified CD4+ Tc e l l s( C D 4 - R N A )a n dC D 4 + T cell-
depleted PBMCs (N-CD4-RNA). In addition, plasma and
pleural effusions were also collected. This work was approval
by and carried out under the guidelines of the Ethical
Committee of the Shenzhen–Hong Kong Institute of Infectious
Disease, Shenzhen Third People’s Hospital and written
informed consent was obtained from all participants involved
in this study directly and not from the next of kin or careers
because all of them are adult.
Microarray Testing
CD4-RNA samples from identical groups (HD, n=11; LTBL,
n=11; LTBH, n=12; TB, n=11) were equally mixed to create
the RNA pools used for the microarray tests. The hybridization
protocol for the human whole-genome oligonucleotide microarray
(Agilent Technologies) and the bioinformatics analysis are shown
in Supporting Information S1 (Microarray Test and Bioinfor-
matics Analysis). The data were deposited in GEO at http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27882.
Real-Time PCR Validation
CD4-RNA was used to validate the 7 genes that were
significantly up-regulated in patients with tuberculosis using real-
time PCR (SYBR Green method). The N-CD4-RNA levels of
BAFF and APRIL were also measured to detect their cellular
distribution. The mRNA values were normalized to the house-
keeping gene b-actin. Details of the real-time PCR protocol
and primer sequences are available in the Online Supplement
(Table S1).
Measurement of Soluble and Membrane-bound Proteins
The levels of soluble BAFF and APRIL were detected in the
plasma, pleural effusion and supernatants of M.tb antigen-
stimulated PBMCs using commercial ELISA kits (Bender
MedSystems). Membrane-bound BAFF, BAFF receptor (BAFFR)
and transmembrane activator and CAML interactor (TACI) on
CD4
+ T cells with/without M.tb antigen stimulation were detected
by flow cytometry. The levels of Th1 cytokines (IFN-c, IL-12p70
and IL-2) in the plasma and pleural effusions were determined
using Luminex platform.
Data Analyses
Unpaired t-tests were used to analyze the difference between
two groups. Pearson’s t-tests were employed to detect correlations
between sAPRIL and the Th1 cytokines. Data are presented as the
means 6 SEM, and differences were considered significant if
P value ,0.05.
Table 1. Subject Characteristics.
Groups
Characteristics HD LTBL LTBH TB TP CA
Total No. 50 35 33 39 21 14
Sex and Age
Female 25 15 11 13 8 9
Male 25 20 22 26 13 5
Age 33.5620 40.7674 6 . 1 66 38.5613 34.0613.3 56.5613.8
TST ,5m m $5m m $20 mm; blister Variable Variable –
SFCs 0,53 0 ,80 110,400 110,400 30,400 –
Definition of abbreviations: HD = healthy donors; LTBL = patients with latent tuberculosis and 30,80 SFCs; LTBH = patients with latent tuberculosis and
110,400 SFCs; TB = pulmonary tuberculosis patients; TP= patients with tuberculosis pleurisy; CA = pulmonary cancer patients; Total No. = total number of
participants in each group; TST = tuberculin skin test; SFCs = Mycobacterium tuberculosis (M.tb)-specific IFN-c spot-forming cells.
The total number of recruited participants in each group included separated samples for microarray analysis and further validation.
doi:10.1371/journal.pone.0038429.t001
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Genome-wide Analysis of CD4
+ T Cell-related Genes
Genome-wide microarray analysis was employed to examine
the gene expression profiles of peripheral CD4
+ T cells. Whole
microarray datasets of CD4
+ T cells from HD, LTBL, LTBH and
TB patients were analyzed using a clustering algorithm. The
cluster analysis indicated that the two latent groups were not
directly related, but the HD and LTBL groups clustered to form a
new category, which then clustered with the LTBH group. The TB
group did not cluster with any group directly (Figure 1.A). The
genes that exhibited significant changes in expression (at least a 2-
fold change between the HD group and other groups) were
selected. Figure 1B shows the number of up- (up arrow) and down-
regulated (down arrow) genes in the LTBL, LTBH and TB groups.
Compared with the HD group, the TB group possessed the largest
number of significantly altered genes, followed by the LTBH and
LTBL groups (Figure 1.B).
To further elucidate biological changes in the peripheral CD4
+
T cells from the LTBL, LTBH and TB groups, enrichment p values
were calculated and used to rank the GO terms (p,0.001,
included significant genes $20) and KEGG pathways (p value
,0.05, included significant genes $10) for each group. The p
value for each individual GO term/KEGG pathway indicates
whether a term or a pathway is significant between analyzed two
groups; the smaller p value indicates the more significance of GO
term/KEGG pathway [13]. Thus, we can speculate the extent of
the effects of certain genes on CD4
+ T cells according to their GO
term/KEGG pathway rankings. The LTBL group had 17 ranked
GO terms, which were involved in responses to stimuli, immune
responses and cell-cell signaling. The LTBH and TB groups had
30 and 34 ranked GO terms, respectively. Beside the GO terms
ranked in the LTBL analysis, significantly altered genes identified
in the LTBH, LTBL, and TB groups were related to protein/RNA
metabolism and protein/nucleic acid modification (Spread Sheet
S1). With regard to ranked KEGG pathways (Figure 1.C), the
significantly altered genes in the LTBL group were annotated to
include 3 ranked KEGG pathways that were mainly involved in
ligand-receptor interactions and antigen processing and presenta-
tion. The LTBH group contained 6 ranked KEGG Pathways,
which were primarily associated with antigen processing and
presentation, cell adhesion, extracellular matrix (ECM)-receptor
interaction, autophagy regulation and p53 signaling. The signif-
icantly altered genes in the TB group were annotated to include 36
ranked KEGG pathways. In addition to the shared pathways of
the LTBL and LTBH groups, the TB group-specific ranked KEGG
pathways were also associated with the regulation of cellular
events, such as signal transduction (in particular the MAPK
signaling pathway), cytoskeletal rearrangement, adhesion, apop-
tosis, autophagy, and metabolism (Spread Sheet S2). These results
suggest that there may be no major differences in CD4
+ T cell
function between TB and LTBH patients.
Validation of TNFSF- and TNFRSF-Associated Genes
Previous studies have reported that the TNFSF and TNFRSF
genes played roles in disease of tuberculosis [10,14]. Further-
more, we noticed that tested genes belonging to the TNF and
TNF receptor superfamilies (TNFSF and TNFRSF, respectively)
exhibited a significant (greater than 2-fold) change in expression
levels in the array test (Table S2). Figure 2.A shows that eight
genes in the TNF and TNFR superfamilies were markedly up-
regulated in the TB group. Therefore, we validated the
expression levels of these genes in purified peripheral CD4
+ T
cells of each group (HD, n=10; LTBL, n=12; LTBH,n=7 ;T B ,
n = 1 0 ) ,w h i c hs a m p l e sw e r en o tt h es a m ef o rg e n o m ea r r a y
assay. Except for the expression levels of TNFR1, the expression
levels of the seven other genes were confirmed by real-time PCR
to be significantly increased in TB patients (Figure 2.B). The
validation of BAFF and APRIL will be shown in the following
section.
Figure 1. Bioinformatics analysis of gene expression in peripheral CD4
+ T cells. A. Whole genome datasets of peripheral CD4
+ T cells were
analyzed by hierarchical clustering. The HD and LTBL groups clustered directly as a new category, which was subsequently clustered with the LTBH
group. The TB group did not directly cluster with any group. B. In accordance with a 2-fold change between LTBL/LTBH/TB and HD, the number of
significantly up-regulated (up arrow) and down-regulated (down arrow) genes were identified in the LTBL, LTBH and TB groups when they were
compared to the HD group. Overlapping areas represent the common significant genes shared by two or three groups. C. The enrichment p value
was used to rank the KEGG pathways (p value ,0.05, included significant gene $10) in the LTBL, LTBH and TB groups. The p value of a KEGG pathway
implies the significance of the KEGG pathway; the smaller the p value, the more significant the KEGG pathway. The TB group had the largest number
of ranked KEGG pathways (36 pathways). The LTBL and LTBH groups had three and six ranked pathways, respectively.
doi:10.1371/journal.pone.0038429.g001
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Among the seven up-regulated genes in the group of TB, we
further studied BAFF and APRIL in detail. BAFF and APRIL are
ligands of the BAFF/APRIL system and expressed on many cells
[15]. To examine the cellular distribution of BAFF and APRIL
expression, we further analyzed the mRNA expression levels of
these genes in peripheral CD4
+ T cells and CD4
+ T cell-depleted
PBMCs. BAFF mRNA was significantly increased in the CD4
+ T
cells of TB patients (TB vs. HD, p=0.0119). An examination of
the N-CD4-RNA samples revealed that BAFF mRNA was
significantly increased in both LTB participants (LTBL vs. HD,
p=0.0049; LTBH vs. HD, p=0.0027) and TB patients (TB vs.
HD, p=0.0007). The significant increase in APRIL mRNA was
only encountered in the CD4
+ T cells of TB patients (TB vs. HD,
p=0.0112), and no significant up- or down-regulation could be
detected in other groups (Figure 3.A). mRNA of the membrane-
bound APRIL [16] ligand TWE-PRIL was not detected in the
CD4-RNA or N-CD4-RNA samples (data not shown).
BAFF and APRIL can be secreted and act as soluble regulators
[17]. Indeed, ELISA tests demonstrated that soluble BAFF
(sBAFF) and soluble APRIL (sAPRIL) were significantly elevated
in the plasma of TB and TP patients (Figure 3.B, TB, n=12 vs.
HD, n=22: both sBAFF and sAPRIL, p,0.0001; TP, n=10 vs.
HD: sBAFF, p=0.0003 and sAPRIL, p,0.0001). The plasma
levels of sBAFF and sAPRIL were not significantly different
between TB and TP patients. However, sBAFF protein levels were
Figure 2. Validation of genes related to the TNF (TNF) and TNF receptor (TNFR) superfamilies (SF). A. Compared with the HD group, the
expression levels of the genes related to the TNFSF and TNFRSF in the LTBL, LTBH and TB groups were analyzed using a clustering algorithm. Eight
genes (TRAIL, BAFF, CD30, APRIL, LTBR, TNFR1, TRAILR3 and CD40) were clustered as an identical category characterized by TB specific up-regulation.
B. Using real-time PCR, we validated the eight TB-specific genes and detected seven genes that were significantly increased in the peripheral CD4
+ T
cells of TB patients. The mRNA values of the validated genes were normalized to the housekeeping gene b-actin. The numbers of participants
included in validation test were the following: HD, n=10; LTBL, n=12; LTBH, n=7; TB, n=10. The validation results among the seven genes of the
pentagram are marked BAFF and APRIL in Figure 3.A.
doi:10.1371/journal.pone.0038429.g002
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were p,0.0001) compared with that of CA patients (n=14),
whereas sAPRIL levels were similar among TB, TP and CA
participants. Both BAFF and APRIL showed the highest
expression in the pleural effusion of TP patients, and the levels
of these proteins were significantly higher than those in the pleural
effusion of CA individuals. In summary, Figure 3.B shows the
tuberculosis-specific up-regulation of BAFF and APRIL. In
particular, the high expression of BAFF and APRIL in the TP
pleural effusion was remarkable.
BAFFR and TACI are the key receptors of the BAFF/APRIL
system [17]. An analysis by flow cytometry revealed that the
frequencies of the CD4
+BAFF
+ (from 0.20% to 2.16%),
CD4
+BAFFR
+ (from 0.26% to 0.37%) and CD4
+TACI
+ (from
1.36% to 5.10%) T cells were slightly increased in the PBMCs of
TB patients (n=2) compared with HD participants (n=2)
(Figure 3.C). After M.tb-specific antigen stimulation, the frequency
of CD4
+BAFFR
+ T cells was enhanced in the PBMCs of TB
patients (n=2) compared with un-stimulated cells (from 0.51% to
1.13%, Figure 3.D). Interestingly, there was less sAPRIL present in
the supernatants of M.tb-stimulated PBMCs (TB-sti) from TB
patients (n=5) than in un-stimulated PBMCs (TB n-sti)
(p=0.0414); furthermore, sAPRIL was not detected in the PBMC
supernatants from HD patients (HD-sti, n=5) upon M.tb antigen
stimulation. The supernatant levels of sBAFF were not signifi-
cantly different between stimulated and un-stimulated cells
(Figure 3.E).
Ingenuity Pathways Analysis For BAFF and/or APRIL-
Related Genes
Ingenuity Pathways Analysis (IPA) is a common method to
depict known interactions among genes [18,19]. To further
decipher possible roles of BAFF and APRIL in disease of
Tuberculosis, IPA was employed to understand the BAFF- and/
or APRIL-related genes represented in the microarray (Figure 4).
Figure 4 shows that there are forty-five BAFF- and/or APRIL-
Figure 3. Detection of the BAFF/APRIL system-related genes. A. BAFF and APRIL mRNA were detected in both peripheral CD4
+ T cells (CD4-
RNA; HD, n=10; LTBL, n=12; LTBH, n=7; TB, n=10) and CD4
+ T cell-depleted PBMCs (N-CD4-RNA; HD, n=6; LTBL, n=12; LTBH, n=7; TB, n=6). The
gene expression levels of BAFF and APRIL were normalized to b-actin. B. Soluble BAFF (sBAFF) and APRIL (sAPRIL) were measured by ELISA in plasma
(HD, n=22; LTBL, n=12; LTBH, n=14; TB, n=11; TP, n=11; CA, n=14) and pleural effusion (TP, n=10; CA, n=14). C. Flow cytometry was employed to
detect BAFF, BAFFR and TACI expression on the surface of peripheral CD4
+ T cells from HD participants (n=2) and TB patients (n=2). D. M.tb antigen
stimulation slightly augmented the frequency of BAFFR
+CD4
+ T cells in PBMCs from TB patients (TB-sti, n=2) compared with un-stimulated cells (TB
n-sti, n=2). E. With or without M.tb antigen stimulation, the levels of sBAFF and sAPRIL were detected by ELISA in the supernatants of PBMCs from TB
patients (n=5). The stimulated supernatants of PBMCs from the HD group (n=5) were used as a control. HD-sti: M.tb antigen-stimulated PBMCs from
HD participants; TB-sti: M.tb antigen-stimulated PBMCs from TB patients; TB n-sti: un-stimulated PBMCs from TB patients.
doi:10.1371/journal.pone.0038429.g003
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apoptosis, immune responses and signal transduction.
Th1 cytokines (IFN-c, IL-2, IL-27 and TNF/TNF-a) were also
identified by IPA, which suggests that there is an intimate
connection between the Th1 response and the BAFF/ARPIL
system. Thus, we examined the levels of Th1 cytokines (IFN-c, IL-
12p70 and IL-2) in plasma (HD, n=15; LTBL, n=11; LTBH,
n=14; TB, n=11) and pleural effusion from TP patients (n=10)
by Luminex platform. IFN-c and IL-12p20 were slightly elevated
in the pleural effusion of TP patients compared with the plasma of
the other groups (Figure 5.A). In the pleural effusion of TP
patients, positive correlations were identified between sAPRIL and
IFN-c (Pearson’s correlation coefficient: r=0.8412, p=0.0023),
IL-12p70 (Pearson’s correlation coefficient: r=0.8211, p=0.0036)
and IL-2 (Pearson’s correlation coefficient: r=0.7424, p=0.0139)
(Figure 5.B). No correlation was found between sBAFF and Th1
cytokines in TP pleural effusion.
Discussion
In the current study, we showed that the two latent TB groups
(LTBL, LTBH) did not cluster closely. Among detected genes,
LTBL and HD clustered as a category, but LTBH is more close to
active Tuberculosis. These results suggest that LTBL and HD
participants have similar gene expression profiles in their
peripheral CD4
+ T cells. Although LTBL and LTBH are both
latent TB classes, their transcription profiles are actually quite
distinct. The TB group did not cluster with any other group
directly, which indicates that the peripheral CD4
+ T cells of these
patients have unique gene expression profiles, and these charac-
teristics help us to well understand TB patients from healthy and
latent participants.
With regard to ranked GO terms or KEGG Pathways, the
significantly altered expression of genes in the LTBL group were
mainlyassociatedwithstimulusresponses,suggestingthattheCD4
+
TcellsoftheLTBLparticipantsmighteasilyrespondtoM.tb-antigen
stimulation. The CD4
+ T cells of the LTBH group could easily
alternate between their roles in movement and metabolism because
many migration- and metabolism-related GO terms were ranked in
the LTBH group. The TB group has the largest number of genes
ranked by GO terms and KEGG pathways. This is reasonable to
assume that the CD4
+ T cells of TB patients do not appear to be
functionally impaired and may possess the mostprotectivepotential
andactforalterationsinmetabolism,migration,adhesion,apoptosis
and respond to stimulus.
Although many studies have confirmed the indispensability of
IFN-c in the prevention of TB development, correlation of IFN-c
levels and protection ability still debate [20]. Therefore, it is
essential to identify other tuberculosis-specific signatures. In this
study, TNFSF and TNFRSF genes were screened for further
validation because some of them have previously been confirmed
to have effects on TB development. TNF-a promotes granuloma
formation, which is involved in preventing the dissemination of
bacilli [10], and anti-TNF-a treatment for rheumatoid arthritis
increases the risk of active tuberculosis development [21]. FAS,
FASLG and CD30 have also been shown to be related to disease
Figure 4. Identification of BAFF- and/or APRIL-related genes. Ingenuity Pathway Analysis (IPA) was used to identify the forty-five BAFF- and/or
APRIL-related genes represented on the microarray. BAFF and APRIL (yellow marked genes) were found to interact with many genes that are involved
in regulating apoptosis, transcription, the immune response and signal transduction. Among these genes, the T helper 1 (Th1)-related genes, such as
IFN-c, IL-2, IL-27 and TNF (namely, TNF-a), were identified to interact with BAFF and/or APRIL. These genes are presented by their common
abbreviated names. According to their direct (solid lines) or indirect (dashed lines) action, these genes can establish contacts with BAFF and/or APRIL.
Lines ending in black arrows indicate an activation pathway, and those ending in white arrows represent a translocation process. Lines joining two
genes indicate binding.
doi:10.1371/journal.pone.0038429.g004
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were also markedly up-regulated in the plasma of tuberculosis
patients (data not shown).
Furthermore, our results indicate that BAFF and APRIL
expression is significantly elevated during active tuberculosis
infections. And, a stronger secretion of soluble BAFF and APRIL
was observed in the pleural effusion of TP patients, which suggests
that the two cytokines are involved in pulmonary and extraplu-
monary Tuberculosis and may reflect disease exacerbation.
Although the levels of sAPRIL were lower in the M.tb antigen-
stimulated supernatants than in un-stimulated supernatants of TB
patients, we hypothesize that the down-regulation of sAPRIL is
caused by its consumption during stimulation because it has been
shown to play an anti-apoptotic role through an autocrine pathway
[24,25].
BAFF and APRIL previously reported as two important
mediators of B cells [17], also affect the survival and activation of
Tcells[26–28].Inparticular,BAFFalsopromotestheTh1response
[29].Certaincytokines,suchasIFN-c,IL-10andIFN-a,caninduce
various cells to augment BAFF production [30,31]. However, IL-4
caninhibitBAFFexpression[31].SimilartoBAFF,APRILhasbeen
showntobeup-regulatedinresponsetoIFN-candIFN-atreatment
[30,32]. In our study, TB and TP patients secreted high antigen
specificIFN-cleveldetectedbyELISPOT(SFCs.110),andplasma
level ofIFN-c were markedly increased inthe pleural effusion of TP
patientsbutwithlowIL-4level (FigureS1).Therefore,the dramatic
enhancement of sBAFF and sAPRIL levels in patients might be
caused by the stronger IFN-c-mediated effects that outweigh the
inhibitory effects of IL-4. The exact mechanisms of sBAFF and
sAPRIL production require further examination. BAFF has two
forms: membrane-bound and soluble [33]. An analysis by flow
cytometry revealed that the frequency of BAFF
+CD4
+ T cells is
increased in TB patients (Figure 3.C). Some studies have suggested
thatonlyimmobilizedBAFFcanenhancethehumanTcellresponse
to anti-CD3/TCR activation [26–28]. Thus, it appears that sBAFF
might act as a suppressor and inhibit the binding of membrane-
bound BAFF to its receptors.
Figure 4 shows there are forty-five known genes that interact
with BAFF and/or APRIL. An IPA analysis was employed to
analyze the interactions and RT-PCR results indicated that a
largest number of pathways emanate from apoptosis-related genes,
such as BCL2 (data not shown). Therefore, network-regulated
apoptosis is important for the fate of CD4
+ T cells and might
indirectly affect tuberculosis outcome. As an autocrine factor
[24,25,34], BAFF has also been reported to induce BCL2 up-
regulation through BAFFR-mediated signaling [35] and to
promote T cell survival [27]. The cytoplasmic tail of BAFFR
has TNF receptor-associated factor (TRAF)-interacting motifs
(TIMs) [36], which are involved in mediating cell survival,
activation and differentiation. Thus, BAFF might prevent periph-
eral CD4
+ T cells from apoptosis in patients and this mechanism
might be related to the induction of BCL2 gene expression.
Figure 4 also shows the intimate association between the Th1
response and the BAFF/APRIL system. The Th1 response plays
an indispensable role in M.tb control and elimination [37–39]. In
particular, sufficient macrophage activation is produced by IFN-c
and IL-12, thus permitting more efficient bacilli destruction [20].
Deficiencies in IL-12 or IFN-c or their receptors render
Figure 5. Analysis of the correlation between Th1 cytokines and sBAFF/sAPRIL. A. The levels of IFN-c, IL-12p70 and IL-2 were detected in
plasma (HD, n=15; LTBL, n=11; LTBH, n=14; TB, n=11) and pleural effusion (TP, n=10) using Luminex technology. B. Significant positive correlations
were identified between sAPRIL, and IFN-c (Pearson’s correlation coefficient, r=0.8412, p=0.0023), IL-12p70 (Pearson’s correlation coefficient
r=0.8211, p=0.0036) and IL-2 (Pearson’s correlation coefficient r=0.7424, p=0.0139) in the TP pleural effusion.
doi:10.1371/journal.pone.0038429.g005
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TNF-a is important for establishing granulomas and the localized
control of M.tb [10]. A few publications revealed that BAFF is
expressed on activated T cells and promotes the Th1 response
[26,28]. BAFF and IFN-c have also been shown to establish an
inflammatory loop between T and myeloid cells that exacerbates
autoimmunity [29]. To our knowledge, no direct relation between
APRIL and the Th1 response has been reported. However, among
the TNFSF-related genes, APRIL is most closely related to BAFF;
they share ,30% sequence identity in their TNF homology
domains (THDs) [42]. APRIL may play a similar role in disease of
Tuberculosis. Moreover, we found strong positive correlations
between Th1 cytokines (IFN-c, IL-12p70 and IL-2) and sAPRIL
in the pleural effusion of TP patients. Thus, these studies suggest a
reciprocal relationship between the BAFF/APRIL system and the
Th1 response in pulmonary and extrapulmonary TB patients. In
our study, we found effects of the BAFF/APRIL system on
tuberculosis to be intriguing. Future studies involving novel ideas
and participants are necessary to discern the role of the BAFF/
APRIL system in the pathogenesis of tuberculosis.
In summary, our results herein suggest that the elevated
expression levels of BAFF and APRIL are associated with active
pulmonary and extrapulmonary tuberculosis and that the BAFF/
APRILsystemisintimatelycorrelatedwiththeTh1response.These
results implicate a potential use for the combination of BAFF and/
or APRIL with IFN-c in the diagnosis of tuberculosis. Moreover,
theCD4
+T cell-derived transcriptionalsignaturesofdistinctlatency
populations might be helpful to identify subsets of latent individuals
that produce protective responses against tuberculosis. However,
longitudinal studies must be performed to assess this hypothesis.
Supporting Information
Figure S1 The Levels of IFN-c and IL-4 in Pleural
Effusion from TP (n=10) and CA (n=5) patients.
Secretion levels of IFN-c and IL-4 were detected in pleural
effusion from TP (tuberculosis pleural, n=10) and CA (lung
cancer, n=5) patients by Luminex.
(TIF)
Spread Sheet S1 An excel spread sheet listing the ranked
GO terms in LTBL, LTBH and TB.
(DOC)
Spread Sheet S2 An excel spread sheet listing the ranked
KEGG pathways in LTBL, LTBH and TB.
(DOC)
Supporting Information S1 Microarray Test and Bioin-
formatics Analysis.
(DOC)
Table S1 Target Genes and Primer Sequences. Primer
pairs of selected genes shown in Table S1. *b-actin was a
housekeeping gene.
(DOC)
Table S2 The Expression Level of TNFSF (A) and
TNFRSF (B) family genes in Microarray Test. Definition
of abbreviations: HD=healthy donors; LTBL=latent tuberculosis
participants with low SFCs; LTBH= latent tuberculosis partici-
pants with high SFCs; TB=pulmonary tuberculosis patients. ID
REF is the ProbeName on microarray. The expression level was
displayed as ratio between every two groups. The fold change $2
or #0.5 between two groups was set as cutoff to select significant
genes. Gray bar indicated the existence of significant genes.
(DOC)
Acknowledgments
We thank Dr. Xinchun Chen, Mingfeng Liao, Xiuyun Zhu and Weilong
Liu (Shenzhen Third People’s Hospital, China) for their assistance in
recruiting samples for this paper.
Author Contributions
Conceived and designed the experiments: HYL QJ. Performed the
experiments: KL YZ SZH YY DDJ QTY. Analyzed the data: HYL QJ.
Contributed reagents/materials/analysis tools: XCC. Wrote the paper:
HYL KL. Clinical sample recruitment: XCC QTY.
References
1. Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum
of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev
Microbiol 7: 845–855.
2. Kaufmann SH, McMichael AJ (2005) Annulling a dangerous liaison: vaccination
strategies against AIDS and tuberculosis. Nat Med 11: S33–44.
3. Young DB, Gideon HP, Wilkinson RJ (2009) Eliminating latent tuberculosis.
Trends Microbiol 17: 183–188.
4. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011)
Human gene expression profiles of susceptibility and resistance in tuberculosis.
Genes Immun 12: 15–22.
5. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An
interferon-inducible neutrophil-driven blood transcriptional signature in human
tuberculosis. Nature 466: 973–977.
6. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007)
Candidate biomarkers for discrimination between infection and disease caused
by Mycobacterium tuberculosis. J Mol Med (Berl) 85: 613–621.
7. Homolka S, Niemann S, Russell DG, Rohde KH (2010) Functional genetic
diversity among Mycobacterium tuberculosis complex clinical isolates: delinea-
tion of conserved core and lineage-specific transcriptomes during intracellular
survival. PLoS Pathog 6: e1000988.
8. Tailleux L, Waddell SJ, Pelizzola M, Mortellaro A, Withers M, et al. (2008)
Probing host pathogen cross-talk by transcriptional profiling of both Mycobac-
terium tuberculosis and infected human dendritic cells and macrophages. PLoS
One 3: e1403.
9. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. (2009) Systems
biology approach predicts immunogenicity of the yellow fever vaccine in
humans. Nat Immunol 10: 116–125.
10. Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19:
93–129.
11. Chen X, Yang Q, Zhang M, Graner M, Zhu X, et al. (2009) Diagnosis of active
tuberculosis in China using an in-house gamma interferon enzyme-linked
immunospot assay. Clin Vaccine Immunol 16: 879–884.
12. Chen X, Zhang M, Liao M, Graner MW, Wu C, et al. (2010) Reduced Th17
response in patients with tuberculosis correlates with IL-6R expression on CD4+
T Cells. Am J Respir Crit Care Med 181: 734–742.
13. Reiner A, Yekutieli D, Benjamini Y (2003) Identifying differentially expressed
genes using false discovery rate controlling procedures. Bioinformatics 19: 368–
375.
14. Budak F, Uzaslan EK, Cangur S, Goral G, Oral HB (2008) Increased pleural
soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-
helper type 1 cytokines. Lung 186: 337–343.
15. Ng LG, Mackay CR, Mackay F (2005) The BAFF/APRIL system: life beyond B
lymphocytes. Mol Immunol 42: 763–772.
16. Daridon C, Youinou P, Pers JO (2008) BAFF, APRIL, TWE-PRIL: who’s who?
Autoimmun Rev 7: 267–271.
17. Mackay F, Schneider P, Rennert P, Browning J (2003) BAFF AND APRIL: a
tutorial on B cell survival. Annu Rev Immunol 21: 231–264.
18. Crouser ED, Culver DA, Knox KS, Julian MW, Shao G, et al. (2009) Gene
expression profiling identifies MMP-12 and ADAMDEC1 as potential
pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med
179: 929–938.
19. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, et al. (2008) Gene
expression profiling in patients with chronic obstructive pulmonary disease and
lung cancer. Am J Respir Crit Care Med 177: 402–411.
20. Kaufmann SH (2001) How can immunology contribute to the control of
tuberculosis? Nat Rev Immunol 1: 20–30.
21. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. (2001)
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-
neutralizing agent. N Engl J Med 345: 1098–1104.
Increased Levels of BAFF/APRIL in Tuberculosis
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e3842922. Hanekom WA, Hussey GD, Hughes EJ, Potgieter S, Yogev R, et al. (1999)
Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity,
nutritional status, and vitamin A therapy. Clin Diagn Lab Immunol 6: 204–208.
23. Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, et al. (1998) Fas
ligand-induced apoptosis of infected human macrophages reduces the viability of
intracellular Mycobacterium tuberculosis. J Immunol 160: 5448–5454.
24. Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, et al. (2004) Involvement
of BAFF and APRIL in the resistance to apoptosis of B-CLL through an
autocrine pathway. Blood 103: 679–688.
25. Chu VT, Enghard P, Schurer S, Steinhauser G, Rudolph B, et al. (2009)
Systemic activation of the immune system induces aberrant BAFF and APRIL
expression in B cells in patients with systemic lupus erythematosus. Arthritis
Rheum 60: 2083–2093.
26. Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, et al. (2005) BAFF
augments certain Th1-associated inflammatory responses. J Immunol 174:
5537–5544.
27. Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, et al. (2004) B cell-
activating factor belonging to the TNF family (BAFF)-R is the principal BAFF
receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol
173: 807–817.
28. Huard B, Schneider P, Mauri D, Tschopp J, French LE (2001) T cell
costimulation by the TNF ligand BAFF. J Immunol 167: 6225–6231.
29. Scapini P, Hu Y, Chu CL, Migone TS, Defranco AL, et al. (2010) Myeloid cells,
BAFF, and IFN-gamma establish an inflammatory loop that exacerbates
autoimmunity in Lyn-deficient mice. J Exp Med 207: 1757–1773.
30. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, et al. (2002) DCs
induce CD40-independent immunoglobulin class switching through BLyS and
APRIL. Nat Immunol 3: 822–829.
31. Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, et al. (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:
198–204.
32. Craxton A, Magaletti D, Ryan EJ, Clark EA (2003) Macrophage- and dendritic
cell–dependent regulation of human B-cell proliferation requires the TNF family
ligand BAFF. Blood 101: 4464–4471.
33. Liu Y, Xu L, Opalka N, Kappler J, Shu HB, et al. (2002) Crystal structure of
sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell 108: 383–394.
34. Huard B, Arlettaz L, Ambrose C, Kindler V, Mauri D, et al. (2004) BAFF
production by antigen-presenting cells provides T cell co-stimulation. Int
Immunol 16: 467–475.
35. Rahman ZS, Manser T (2004) B cells expressing Bcl-2 and a signaling-impaired
BAFF-specific receptor fail to mature and are deficient in the formation of
lymphoid follicles and germinal centers. J Immunol 173: 6179–6188.
36. Dempsey PW, Doyle SE, He JQ, Cheng G (2003) The signaling adaptors and
pathways activated by TNF superfamily. Cytokine Growth Factor Rev 14: 193–
209.
37. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993)
Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med
178: 2243–2247.
38. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An
essential role for interferon gamma in resistance to Mycobacterium tuberculosis
infection. J Exp Med 178: 2249–2254.
39. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, et al. (1993) Multiple
defects of immune cell function in mice with disrupted interferon-gamma genes.
Science 259: 1739–1742.
40. Alcais A, Fieschi C, Abel L, Casanova JL (2005) Tuberculosis in children and
adults: two distinct genetic diseases. J Exp Med 202: 1617–1621.
41. Jouanguy E, Doffinger R, Dupuis S, Pallier A, Altare F, et al. (1999) IL-12 and
IFN-gamma in host defense against mycobacteria and salmonella in mice and
men. Curr Opin Immunol 11: 346–351.
42. Dillon SR, Gross JA, Ansell SM, Novak AJ (2006) An APRIL to remember:
novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5: 235–246.
Increased Levels of BAFF/APRIL in Tuberculosis
PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38429